The addition of a MAPK/ERK kinase (MEK) inhibitor to a dual PI3K-mTOR inhibitor significantly enhanced the inhibition of tumor growth by a dual PI3K-mTOR inhibitor alone in human neuroendocrine cell lines [19]. The gene discussed is PIK3CA; the disease is neoplasm.